What is a Form 4?
A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.
The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.
Read one actual disclosure before using it
Show the table · 1 row, 6 columns
Scroll sideways to compare all columns. Select a heading to sort.
| 2026-08-28 | 2026-08-26 | IMTX | P | 863,060 | Not reported |
No matching rows. Clear the filter to see all records.
First displayed source row from Recent SEC transactions. The full bounded history and coverage notes remain below.
The displayed observation date is 2026-08-26 and its public availability date is 2026-08-28. Subtracting those calendar dates gives 2 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.
This row is code P: a purchase. A purchase code is only one eligibility check. Confirm reporting-owner role, amendment lineage and coverage before treating it as a strategy input.
Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.
Issuer relationships
Inspect all 50 displayed rows: Issuer relationships
A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.
Scroll sideways to compare all columns. Select a heading to sort.
| INDEVUS PHARMACEUTICALS INC | 0000854222 | IDEV | No | No |
| BIOENVISION INC | 0001028205 | BIVN | No | No |
| MACROCHEM CORP | 0000743884 | MACM.OB | No | No |
| XTL BIOPHARMACEUTICALS LTD | 0001023549 | XTLB | No | No |
| OPTIMER PHARMACEUTICALS INC | 0001142576 | OPTR | No | No |
| PENWEST PHARMACEUTICALS CO | 0001047188 | PPCO | No | No |
| SYNAGEVA BIOPHARMA CORP | 0000911326 | TRMS | No | No |
| REPROS THERAPEUTICS INC. | 0000897075 | RPRX | No | No |
| Aegerion Pharmaceuticals, Inc. | 0001338042 | AEGR | No | No |
| ACELRX PHARMACEUTICALS INC | 0001427925 | ACRX | No | No |
| AMICUS THERAPEUTICS, INC. | 0001178879 | FOLD | No | No |
| VBI VACCINES INC. | 0000704159 | VBIV | No | No |
| Aldeyra Therapeutics, Inc. | 0001341235 | ALDX | No | No |
| Versartis, Inc. | 0001513818 | VSAR | No | No |
| Kadmon Holdings, Inc. | 0001557142 | KDMN | No | No |
| ZOGENIX, INC. | 0001375151 | ZGNX | No | No |
| Corium International, Inc. | 0001594337 | CORI | No | No |
| Quotient Ltd | 0001596946 | QTNT | No | No |
| VBI Vaccines Inc/BC | 0000764195 | VBIV | No | No |
| ADMA BIOLOGICS, INC. | 0001368514 | ADMA | No | No |
| ALBIREO PHARMA, INC. | 0001322505 | ALBO | No | No |
| Global Blood Therapeutics, Inc. | 0001629137 | GBT | No | No |
| LA JOLLA PHARMACEUTICAL CO | 0000920465 | LJPC | No | No |
| Solid Biosciences Inc. | 0001707502 | SLDB | No | Yes |
| Motus GI Holdings, Inc. | 0001686850 | MOTS | No | No |
| AGILE THERAPEUTICS INC | 0001261249 | AGRX | No | No |
| Dova Pharmaceuticals Inc. | 0001685071 | DOVA | No | No |
| MeiraGTx Holdings plc | 0001735438 | MGTX | No | Yes |
| Crinetics Pharmaceuticals, Inc. | 0001658247 | CRNX | No | No |
| Verrica Pharmaceuticals Inc. | 0001660334 | VRCA | No | No |
| ARYA SCIENCES ACQUISITION CORP. | 0001746037 | ARYA | No | Yes |
| Athenex, Inc. | 0001300699 | ATNX | No | No |
| Foamix Pharmaceuticals Ltd. | 0001606645 | FOMX | No | No |
| LEAP THERAPEUTICS, INC. | 0001509745 | LPTX | No | No |
| Lyra Therapeutics, Inc. | 0001327273 | LYRA | No | Yes |
| Cerevel Therapeutics Holdings, Inc. | 0001805387 | ARYB, CERE | No | Yes |
| Yarrow Bioscience, Inc. | 0001566044 | MNLO, VYNE, YARW | No | Yes |
| Nautilus Biotechnology, Inc. | 0001808805 | ARYA, NAUT | No | Yes |
| LeonaBio, Inc. | 0001620463 | ATHA, LONA | No | Yes |
| SCYNEXIS INC | 0001178253 | SCYX | No | No |
| Landos Biopharma, Inc. | 0001785345 | LABP | No | Yes |
| Astria Therapeutics, Inc. | 0001454789 | CATB, ATXS | No | Yes |
| ARYA Sciences Acquisition Corp IV | 0001838821 | ARYD | No | Yes |
| Prometheus Biosciences, Inc. | 0001718852 | RXDX | No | No |
| Rain Therapeutics Inc. | 0001724979 | RAIN | No | No |
| ARYA Sciences Acquisition Corp V | 0001852432 | ARYE | No | Yes |
| IsoPlexis Corp | 0001615055 | ISO | No | No |
| LianBio | 0001831283 | LIAN | No | Yes |
| Acrivon Therapeutics, Inc. | 0001781174 | ACRV | No | No |
| CHEMBIO DIAGNOSTICS, INC. | 0001092662 | CEMI | No | No |
No matching rows. Clear the filter to see all records.
Recent SEC transactions
Inspect all 50 displayed rows: Recent SEC transactions
Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.
Scroll sideways to compare all columns. Select a heading to sort.
| 2026-08-28 | 2026-08-26 | IMTX | P | 863,060 | Not reported |
| 2026-07-23 | 2026-07-20 | FRNM | A | 5,500,000 | Not reported |
| 2026-07-14 | 2026-06-17 | KARD | A | 20,706 | Not reported |
| 2026-07-11 | 2026-04-09 | LONA | A | 28,000 | Not reported |
| 2026-07-10 | 2026-06-23 | LONA | A | 28,000 | Not reported |
| 2026-06-25 | 2026-06-23 | LONA | A | 28,000 | Not reported |
| 2026-06-16 | 2026-06-11 | MGTX | A | 60,000 | Not reported |
| 2026-06-12 | 2026-06-10 | SLDB | A | 77,500 | Not reported |
| 2026-04-24 | 2026-04-17 | MGTX | A | 555,555 | Not reported |
| 2026-04-24 | 2026-03-25 | MGTX | A | 300,000 | Not reported |
| 2026-04-24 | 2026-03-25 | MGTX | A | 400,000 | Not reported |
| 2026-04-24 | 2022-08-02 | MGTX | A | 300,000 | Not reported |
| 2026-04-24 | 2022-08-02 | MGTX | A | 400,000 | Not reported |
| 2026-04-14 | 2026-04-09 | LONA | A | 28,000 | Not reported |
| 2026-03-12 | 2026-03-09 | SLDB | A | 8,912,655 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 329,756 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 989,270 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 5,502,402 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 1,181,101 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 1,279,526 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 457,645 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 3,543,307 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 3,838,583 | Not reported |
| 2025-12-24 | 2025-12-23 | ATHA | A | 1,372,935 | Not reported |
| 2025-11-14 | 2025-11-13 | LYRA | S | 3,213 | Not reported |
| 2025-11-14 | 2025-11-13 | LYRA | S | 28,597 | Not reported |
| 2025-11-14 | 2025-11-12 | LYRA | S | 883 | Not reported |
| 2025-11-14 | 2025-11-12 | LYRA | S | 7,862 | Not reported |
| 2025-11-14 | 2025-11-11 | LYRA | S | 537 | Not reported |
| 2025-11-14 | 2025-11-11 | LYRA | S | 4,783 | Not reported |
| 2025-11-11 | 2025-11-10 | LYRA | S | 1,869 | Not reported |
| 2025-11-11 | 2025-11-10 | LYRA | S | 16,633 | Not reported |
| 2025-11-11 | 2025-11-07 | LYRA | S | 1,993 | Not reported |
| 2025-11-11 | 2025-11-07 | LYRA | S | 17,746 | Not reported |
| 2025-11-11 | 2025-11-06 | LYRA | S | 3,247 | Not reported |
| 2025-11-11 | 2025-11-06 | LYRA | S | 28,902 | Not reported |
| 2025-10-23 | 2025-10-20 | ADGM | P | 2,190,496 | Not reported |
| 2025-10-23 | 2025-10-20 | ADGM | P | 1,344,999 | Not reported |
| 2025-10-23 | 2025-10-20 | ADGM | P | 1,344,999 | Not reported |
| 2025-10-23 | 2025-10-20 | ADGM | P | 1,344,999 | Not reported |
| 2025-08-06 | 2025-08-01 | OBIO | P | 700,000 | Not reported |
| 2025-08-06 | 2025-08-01 | OBIO | P | 1,500,000 | Not reported |
| 2025-06-17 | 2025-06-12 | MGTX | A | 45,000 | Not reported |
| 2025-06-14 | 2025-06-12 | SLDB | A | 77,500 | Not reported |
| 2025-06-04 | 2025-05-30 | ATHA | A | 20,900 | Not reported |
| 2025-05-02 | 2025-05-01 | ACRV | S | 298,886 | Not reported |
| 2025-05-02 | 2025-04-30 | ACRV | S | 437,881 | Not reported |
| 2025-04-30 | 2025-04-29 | ACRV | S | 250,000 | Not reported |
| 2025-04-30 | 2025-04-28 | ACRV | S | 215,283 | Not reported |
| 2025-04-30 | 2025-04-25 | ACRV | S | 1,054,669 | Not reported |
No matching rows. Clear the filter to see all records.
Up to 50 transactions from the recent two-year owner window.
Source evidence and strategy eligibility
The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.
Inspect the coverage status above, the filing availability dates and amendment links when defining a historical signal. Follow the issuer CIK and SEC accession to the source transaction.